Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for stage II-IIIA non-small cell lung cancer
Phase 2
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000016191
- Lead Sponsor
- Division of Chest Surgery, Toho University Omori Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Not provided
Exclusion Criteria
1)Drug allergy 2)Administering Flucytosine 3)Interstitial pneumonia 4)Serious medical complications 5)Diarrhea 6)Active double malignancies 7)Mental status 8)Pregnancy, breastfeeding or suspected of being pregnant 9)Pneumonectomy 10)Others judged by attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method